EMTALA investigations occur when the Centers for Medicare & Medicaid Services (CMS) receives a complaint alleging that a hospital turned away, inadequately screened, or improperly transferred someone seeking emergency care. Most investigations are complaint-driven rather than routine, meaning they’re triggered by a specific incident report rather than a scheduled audit. Understanding the timeline and process helps clarify what happens after a complaint is filed and how quickly enforcement can escalate.
What Triggers an Investigation
EMTALA investigations almost always begin with a complaint. These complaints can come from patients, family members, hospital staff, or other hospitals. Receiving hospitals have a particularly important role: if a patient arrives via transfer and the receiving facility suspects the transferring hospital violated EMTALA, it can report the incident directly to CMS.
CMS reviews each complaint and determines whether the hospital may have failed to meet its obligations under its Medicare provider agreement. Not every complaint leads to a full investigation. CMS screens the details first, looking for indicators that a hospital may have denied an appropriate medical screening exam, failed to stabilize an emergency condition, or transferred a patient without meeting the legal requirements for a safe and appropriate transfer. If the complaint appears credible, CMS authorizes a state survey agency to begin an on-site investigation.
How Quickly Investigations Start
Once CMS’s regional office authorizes an investigation, the state survey agency must initiate it within two business days. These are unannounced visits. Investigators arrive at the hospital without prior notice to observe operations and review records as they exist in real time.
After the on-site survey is complete, the timeline depends on what investigators find. If it appears a violation occurred, the investigation paperwork must be submitted to CMS’s regional office within 10 business days of completing the survey. If no violation is apparent, the agency has up to 15 business days to finalize and submit its report. These are tight turnarounds by regulatory standards, reflecting the seriousness CMS places on emergency care access.
The Role of Medical Peer Review
Clinical judgment calls don’t get decided by surveyors alone. CMS refers cases to a Quality Improvement Organization (QIO) for an independent medical opinion. The QIO reviews whether the patient actually had an emergency medical condition, whether the screening exam was appropriate, whether the hospital adequately stabilized the patient, and whether any transfer met legal requirements.
The QIO has 60 calendar days from receiving the case to submit its findings to CMS. This expert medical opinion carries significant weight in determining whether a violation occurred, especially in cases where the hospital argues its clinical decisions were reasonable. The QIO review runs parallel to the investigation process, so it doesn’t necessarily delay the enforcement timeline, but it does shape the final determination.
What Happens When a Violation Is Found
CMS has two enforcement tracks depending on the severity of the violation, and the distinction between them dramatically affects the timeline.
For violations that pose immediate jeopardy to patient health or safety, CMS moves fast. The hospital receives a preliminary notice that its Medicare provider agreement will be terminated in 23 days unless it corrects the deficiency or successfully disputes the finding. If the hospital doesn’t resolve the issue, CMS issues a final termination notice with at least two, but no more than four, days of advance warning. CMS also notifies the public at the same time.
For violations that are serious but don’t rise to the level of immediate jeopardy, the hospital gets a 90-day termination track. This gives the facility more time to implement corrective measures and demonstrate compliance before losing its Medicare participation. In either scenario, termination of a Medicare provider agreement is the most severe consequence, effectively cutting off a hospital’s largest source of reimbursement.
Financial Penalties for Hospitals and Physicians
Beyond the threat of losing Medicare participation, CMS can refer cases to the HHS Office of Inspector General (OIG) for civil monetary penalties. The OIG independently evaluates each referral and decides whether to pursue fines.
As of the most recent inflation adjustment in 2024, the maximum penalty per violation is $133,420 for hospitals with 100 or more beds and for individual physicians found responsible. Smaller hospitals (under 100 beds) face a maximum of $66,712 per violation. These penalties apply per incident, so a pattern of violations can result in substantial cumulative fines. The OIG has discretion in setting the actual penalty amount, and not every confirmed violation results in the maximum fine.
How Long the Full Process Takes
From complaint to resolution, the timeline varies widely. The initial on-site investigation can happen within days of authorization. The QIO medical review adds up to 60 days. If a violation is confirmed and CMS pursues enforcement, the hospital enters either the 23-day or 90-day corrective track. Financial penalty cases referred to the OIG take additional time as that office conducts its own evaluation.
In practice, straightforward cases with clear evidence can move from complaint to enforcement action within a few months. Complex cases involving disputed clinical judgment, multiple patients, or contested transfers can stretch longer, particularly if the hospital challenges the findings. Hospitals that correct deficiencies quickly and demonstrate systemic changes may avoid the most severe consequences, but the investigation itself remains on their compliance record.
Recent Changes to EMTALA Enforcement
EMTALA enforcement has remained active, but the scope of guidance has shifted. In June 2025, CMS rescinded 2022 guidance that had specifically reinforced EMTALA obligations related to pregnant patients and pregnancy loss. The current administration stated it would continue enforcing EMTALA’s protections for all individuals presenting to emergency departments, including pregnant women and their unborn children, while aiming to resolve what it described as legal confusion created by the prior guidance. The core investigative process and timelines remain unchanged, but hospitals should be aware that the interpretive framework around specific clinical scenarios continues to evolve.